Skip to main content
. 2022 May;10(9):519. doi: 10.21037/atm-22-1430

Figure 9.

Figure 9

Patients with high and low SLC2A1 expression had different sensitivities to chemotherapy drugs and targeted drugs. (A-F) The sensitivity of patients with low SLC2A1 expression to six chemotherapy drugs was significantly higher than that of patients with high SLC2A1 expression; (G,H) patients with high SLC2A1 expression were significantly more sensitive to the two targeted therapies than those with low SLC2A1 expression.